Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIOP) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Fortress Biotech (FBIOP) over the last 13 years, with Q3 2025 value amounting to $2.9 million.

  • Fortress Biotech's Cash from Investing Activities changed N/A to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.9 million, marking a year-over-year decrease of 764444.44%. This contributed to the annual value of -$15.0 million for FY2024, which is 61326.68% down from last year.
  • Fortress Biotech's Cash from Investing Activities amounted to $2.9 million in Q3 2025.
  • In the past 5 years, Fortress Biotech's Cash from Investing Activities ranged from a high of $53.4 million in Q4 2021 and a low of -$21.3 million during Q1 2022
  • For the 5-year period, Fortress Biotech's Cash from Investing Activities averaged around $662750.0, with its median value being -$424500.0 (2021).
  • Per our database at Business Quant, Fortress Biotech's Cash from Investing Activities surged by 350478.62% in 2021 and then plummeted by 2370952.38% in 2024.
  • Over the past 5 years, Fortress Biotech's Cash from Investing Activities (Quarter) stood at $53.4 million in 2021, then tumbled by 100.73% to -$391000.0 in 2022, then surged by 83.89% to -$63000.0 in 2023, then crashed by 23709.52% to -$15.0 million in 2024, then surged by 119.13% to $2.9 million in 2025.
  • Its Cash from Investing Activities was $2.9 million in Q3 2025, compared to $6.1 million in Q2 2025 and $1.2 million in Q1 2025.